Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy
dc.contributor.author | Spicer, Robert L. | en_US |
dc.contributor.author | Rocchini, Albert P. | en_US |
dc.contributor.author | Crowley, Dennis C. | en_US |
dc.contributor.author | Rosenthal, Amnon | en_US |
dc.date.accessioned | 2006-04-07T18:27:40Z | |
dc.date.available | 2006-04-07T18:27:40Z | |
dc.date.issued | 1984-06-01 | en_US |
dc.identifier.citation | Spicer, Robert L., Rocchini, Albert P., Crowley, Dennis C., Rosenthal, Amnon (1984/06/01)."Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy." The American Journal of Cardiology 53(11): 1614-1619. <http://hdl.handle.net/2027.42/24807> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T10-4BW0V81-2YS/2/4a1948951de1806669d5a4941d2508e7 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24807 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6539561&dopt=citation | en_US |
dc.description.abstract | Oral verapamil, 5.2 +/- 1.1 mg/kg/day (range 2.8 to 7), was administered to 13 pediatric patients with hypertrophic Cardiomyopathy for 13 +/- 6 months (range 2 to 20). The patients had significant symptomatic improvement on verapamil therapy. Murmur intensity diminished in 6 patients during therapy and left ventricular (LV) electromotive forces on the electrocardiogram diminished in 4, increased in 5 and did not change in 4. Exercise endurance increased from 8.4 +/- 3.9 to 10.9 +/- 2.8 minutes (p < 0.01). Seven patients had ST-segment depression (0.38 +/- 0.28 mV) before verapamil therapy, which improved after verapamil therapy in 5 (0.24 +/- 0.17 mV, p < 0.02). Of 4 patients with exercise-induced ventricular ectopic activity, 3 had diminution or abolishment of ectopy following verapamil. By echocardiography, the patients had an increase in LV end-diastolic dimension from 3.4 +/- 0.7 to 3.9 +/- 0.8 cm (p < 0.01), with no significant change in shortening fraction (46.1 +/- 8.0% vs 44.6 +/- 8.0%). When adjusted for body size and age there was a significant decrease in LV septal thickness (from 106 +/- 70 to 45 +/- 52% of predicted normal values, p < 0.05) and LV posterior wall thickness (from 40 +/- 45 to 5 +/- 26% of predicted normal values p = 0.05) after verapamil. Isovolumic relaxation time decreased from 69 +/- 26 to 42 +/- 19 ms after verapamil (p < 0.01). Systolic anterior motion of the anterior mitral leaflet disappeared in 5 of 8 patients and midsystolic closure of the aortic valve was no longer present in 4 of 8. Chronic oral verapamil appears to be an effective form of therapy for pediatric patients with hypertrophic Cardiomyopathy. | en_US |
dc.format.extent | 847638 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics and the Clinical Research Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA; Division of Pediatric Cardiology, C. S. Mott Children's Hospital, Ann Arbor, Michigan, USA. | en_US |
dc.contributor.affiliationum | Division of Pediatric Cardiology, C. S. Mott Children's Hospital, Ann Arbor, Michigan, USA; Department of Pediatrics and the Clinical Research Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA. | en_US |
dc.contributor.affiliationum | Department of Pediatrics and the Clinical Research Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA; Division of Pediatric Cardiology, C. S. Mott Children's Hospital, Ann Arbor, Michigan, USA. | en_US |
dc.contributor.affiliationum | Department of Pediatrics and the Clinical Research Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA; Division of Pediatric Cardiology, C. S. Mott Children's Hospital, Ann Arbor, Michigan, USA. | en_US |
dc.identifier.pmid | 6539561 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24807/1/0000233.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-9149(84)90589-7 | en_US |
dc.identifier.source | The American Journal of Cardiology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.